Ditchcarbon
  • Contact
  1. Organizations
  2. LNK International
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 2 months ago

LNK International Sustainability Profile

Company website

LNK International, a prominent player in the global healthcare industry, is headquartered in the United States, with significant operations across North America and Europe. Founded in 1988, the company has established itself as a leader in the development and manufacturing of high-quality pharmaceutical products, including over-the-counter medications and dietary supplements. LNK International is renowned for its commitment to innovation and quality, offering unique formulations that cater to diverse consumer needs. With a strong market position, the company has achieved notable milestones, including numerous partnerships with major retailers and a robust portfolio of proprietary brands. LNK International continues to set industry standards, driven by its dedication to enhancing health and wellness worldwide.

DitchCarbon Score

How does LNK International's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

LNK International's score of 23 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.

34%

Let us know if this data was useful to you

LNK International's reported carbon emissions

LNK International, headquartered in the US, currently does not have available carbon emissions data for the most recent year. As a result, specific figures regarding their total emissions, including Scope 1, 2, and 3, are not provided. The company has not outlined any documented reduction targets or commitments to climate initiatives, indicating a lack of formalised strategies in this area. Furthermore, there are no climate pledges or initiatives such as SBTi (Science Based Targets initiative) or CDP (Carbon Disclosure Project) reported. As LNK International does not inherit emissions data from a parent company, all information is based solely on their own reporting. Without specific emissions data or reduction commitments, it is unclear how LNK International is addressing its carbon footprint or contributing to climate action within its industry.

How Carbon Intensive is LNK International's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. LNK International's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is LNK International's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for LNK International is in US, which has a low grid carbon intensity relative to other regions.

LNK International's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

LNK International has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare LNK International's Emissions with Industry Peers

Worldwide

US
•
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

Syneos Health US, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 2 months ago

Dr Reddys Laboratories

IN
•
Pharmaceutical Preparation Manufacturing
Updated 11 days ago

AccuMed, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 2 months ago

Ranbaxy Inc.

US
Updated 5 months ago

P AND L DEVELOPMENT LLC

US
•
Pharmaceutical Preparation Manufacturing
Updated 15 days ago

Let us know if this data was useful to you

Usage Policy

You're welcome to quote or reference data from this page, but please include a visible link back to this URL.

Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.

See our License Agreement for more details.

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251211.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
Available onAWS Marketplace logo
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
Use CaseSBTi-aligned baselining & progress trackingSupplier EngagementClimate-informed sourcing strategyEmission ReportingSustainable Finance
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelogWhitepaper
AboutTeamCareersLicense AgreementPrivacy